Eupraxia Pharmaceuticals - Bathi perusahaan sadurunge pajak, bunga, lan amortisasi EPRX
Geopolitical tensions and logistical barriers are limiting the expansion of new drugs, narrowing target markets. The operating profit of Eupraxia Pharmaceuticals (EPRX) on this chart allows for an assessment of financial stability against this backdrop, where the value of 0.00 shows the current figure. Growth potential is driven by a flexible R&D staff of biochemists and the innovative DiffuSphere system for combating chronic pain.
Eupraxia Pharmaceuticals Inc. (EPRX) - rincian metrik lan laporan keuangan
- nilai pasar lan prakiraan target analis:
- rincian nilai pasar emiten:
- statistik nilai buku emiten:
- rincian struktur utang lan likuiditas bisnis:
Rasio Kabeh Utang marang Dana Pribadi Eupraxia Pharmaceuticals|EPRX - Utang jangka dawa marang modal|Kewajiban jangka cendhak marang modal eupraxiapharma.com|EPRX - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku Eupraxia Pharmaceuticals, Inc.|EPRX - Utang jangka dawa perusahaan|Kewajiban jangka cendhak Eupraxia Pharmaceuticals|Rasio jangkoan perantara eupraxiapharma.com
- statistik bathi lan rasio pasar:
EPRX - Bathi resik|Proyeksi bathi mangsa ngarep Eupraxia Pharmaceuticals|EPRX - Koefisien rega marang bathi|Rasio rega marang bathi mangsa ngarep Eupraxia Pharma|EPRX - Pangali PEG|Rasio total nilai perusahaan marang bathi operasional sadurunge panyusutan Eupraxia Pharmaceuticals Inc.|EPRX - Bathi operasional EBITDA|Bathi resik saben saham (EPS TTM) Eupraxia Pharmaceuticals|EPRX - Bathi resik saben saham sajrone 12 wulan pungkasan|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan eupraxiapharma.com|EPRX - Wutah bathi saben saham ing taun lumaku|Prakiraan owah-owahan bathi resik saben saham kanggo taun ngarep Eupraxia Pharmaceuticals
- indikator pendapatan dodolan lan penghasilan bisnis:
Pambiji fundamental perusahaan:EPRX (Eupraxia Pharmaceuticals Inc.)
The patent protection of Eupraxia Pharmaceuticals (EPRX) and the complexity of establishing sterile laboratories create a sustainable market moat that directly impacts cash flow. The EBITDA_Co metric reflects the daily liquidity inflow from core operations, aggregating institutional expectations regarding business efficiency, where any movement in the curve signals the balance between current yield and long-term market risks.
Pesaing Eupraxia Pharmaceuticals (EPRX)
Bathi perusahaan sadurunge pajak, bunga, lan amortisasi HLN (Haleon plc)|KVUE: Bathi operasional sadurunge ngurangi amortisasi|Verona Pharma - Bathi perusahaan sadurunge pajak, bunga, lan amortisasi|MENS: Bathi operasional EBITDA|Ligand Pharma - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|AMRX (Amneal Pharmaceuticals, Inc.) - Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi perrigo.com PRGO|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Alvotech SA (ALVO)|LQDA (Liquidia Corp) - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi operasional EBITDA GLPG (Galapagos N.V.)|Bathi operasional EBITDA ANI Pharmaceuticals Corp ANIP|Afrezza - Bathi operasional EBITDA|amphastar.com (AMPH) - Bathi operasional sadurunge ngurangi amortisasi|PCRX: Bathi operasional EBITDA|SPRY - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Theravance|Bathi sadurunge bunga, pajak, lan amortisasi Aquestive Corp AQST|Bathi operasional EBITDA SCPH|TECX - Bathi sadurunge bunga, pajak, lan amortisasi|Tonix Pharmaceuticals Holding Corp. - Bathi operasional sadurunge ngurangi amortisasi|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi SXTC|BHST: Bathi operasional sadurunge ngurangi amortisasi|Bathi sadurunge bunga, pajak, lan amortisasi Invizyne|Oramed Pharmaceuticals Inc. (ORMP) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|ENTX (Entera Bio Ltd) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi operasional sadurunge ngurangi amortisasi HYFT|ABVC BioPharma, Inc. - Bathi sadurunge ngurangi bunga, pajak, penyusutan, lan amortisasi|Bathi operasional EBITDA CPIX|Pendapatan operasional sadurunge ngurangi amortisasi Quantum BioPharma Corp|Bathi sadurunge mbayar bunga, pajak, lan amortisasi FibroGen FGEN|Bathi operasional EBITDA telomirpharma.com TELO|Rani Therapeutics Inc - Bathi operasional EBITDA|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi SNYR (synergychc.com)|Rallybio (RLYB) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi operasional sadurunge ngurangi amortisasi Lexaria Bioscience Corp|Bathi operasional sadurunge ngurangi amortisasi PULM|PTHL - Bathi operasional sadurunge potongan amortisasi|Bathi operasional EBITDA APM|Pendapatan operasional sadurunge ngurangi amortisasi Lyra Therapeutics|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Impact BioMedical Inc IBO|TNFA - Bathi operasional sadurunge ngurangi amortisasi|cbdMD, Inc. - Bathi operasional EBITDA|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi PRFX (PainReform Ltd.)|CYTO (altamiratherapeutics.com) - Bathi operasional sadurunge ngurangi amortisasi|LIPO: Bathi perusahaan sadurunge pajak, bunga, lan amortisasi|OPTN (Optinose) - Bathi operasional EBITDA|Bathi operasional sadurunge ngurangi amortisasi Pieris (PIRS)|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Procaps Group S.A. (PROC)|Bathi operasional EBITDA petrospharma.com (PTPI)|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Qilian International Holding QLI|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi SLRN|TFF Pharmaceuticals, Inc. - Bathi operasional EBITDA
